Literature DB >> 22443371

Is podoplanin expression associated with the proliferative activity of ameloblastomas?

K C Tjioe1, D T Oliveira, C T Soares, J R P Lauris, J H Damante.   

Abstract

OBJECTIVES: The aim of this study was to investigate the relationship between podoplanin expression and proliferative activity of ameloblastomas and remnants of the odontogenic epithelium from dental follicles (DF) of unerupted teeth. SUBJECTS AND METHODS: Thirty-three paraffin-embedded ameloblastomas and thirty-two DF obtained of unerupted teeth were analyzed by immunohistochemistry using anti-human podoplanin and anti-Ki-67 antibodies. Podoplanin expression in odontogenic epithelial cells was evaluated using a scoring method, and the Ki-67 labeling index was determined by the percentage of positive odontogenic cells.
RESULTS: All ameloblastomas displayed podoplanin expression in ameloblast-like cells of the epithelial islands. Membranous expression of podoplanin in ameloblastomas was stronger than in the remnants of odontogenic epithelium (P = 0.001). Statistically significant difference was observed between the cytoplasmic and membranous expression of podoplanin in the remnants of odontogenic epithelium (P = 0.001). The index of epithelial odontogenic proliferative activity, verified by Ki-67 expression, was higher in ameloblastomas vs remnants of odontogenic epithelium (P < 0.001). No statistically significant correlation was identified between podoplanin and the cellular odontogenic proliferative activity in meloblastomas and DF (P > 0.05).
CONCLUSIONS: These results provide evidence that there is no connection between podoplanin immunostaining and odontogenic cellular proliferative activity and suggest a role for membranous podoplanin expression in the local invasion of ameloblastomas.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22443371     DOI: 10.1111/j.1601-0825.2012.01924.x

Source DB:  PubMed          Journal:  Oral Dis        ISSN: 1354-523X            Impact factor:   3.511


  7 in total

1.  Immunohistochemical evaluation of podoplanin in odontogenic tumours & cysts using anti-human podoplanin antibody.

Authors:  Namrata Singhal; Nitin Khanduri; Deepak Kurup; Brijesh Gupta; Pranjan Mitra; Roshani Chawla
Journal:  J Oral Biol Craniofac Res       Date:  2017-05-17

2.  Role of podoplanin expression in deciding the invasive potential of ameloblastoma - A retrospective IHC study.

Authors:  Sindhu M Ganvir; Pratima G Khobragade; Swati A Bamane; Ramnivas Kumavat; Amit Dalmia
Journal:  J Oral Biol Craniofac Res       Date:  2016-07-14

3.  Expression of podoplanin and prognosis in oropharyngeal cancer.

Authors:  Simon F Preuss; Andreas Anagiotos; Inga M C Seuthe; Uta Drebber; Inga Wedemeyer; Matthias Kreppel; Robert Semrau; Guy D Eslick; Jens Peter Klussmann; Christian U Huebbers
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-06-01       Impact factor: 2.503

4.  Are podoplanin and ezrin involved in the invasion process of the ameloblastomas?

Authors:  Y F Costa; K C Tjioe; S Nonogaki; F A Soares; J R Pereira Lauris; D Tostes Oliveira
Journal:  Eur J Histochem       Date:  2015-02-24       Impact factor: 3.188

5.  Bilocular unicystic ameloblastoma of the mandible in a 9 yr old child - A diagnostic and management dilemma.

Authors:  Faisal Al Sineedi; Yasin Alavi Aruveetil; Abdul Majeed Kavarodi; Shawqi Osman Harbi
Journal:  Saudi Dent J       Date:  2018-03-13

6.  Assessment of expression of podoplanin in odontogenic tumors and cysts-An immunohistochemical study.

Authors:  Rohit Singh; Malwika Sisodia; Ranjan Sengupta; Annu Prakash Bhindwar; Karuna Bharti; Md Abu Nafe
Journal:  J Family Med Prim Care       Date:  2020-02-28

7.  The relationship between ezrin and podoplanin expressions in keratocystic odontogenic tumors.

Authors:  Denise Tostes Oliveira; Laís Priscila de Santis; Agnes Assao; Kellen Cristine Tjioe; Suely Nonogaki; José Roberto Pereira Lauris; Fernando Augusto Soares
Journal:  BMC Oral Health       Date:  2014-12-05       Impact factor: 2.757

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.